For biologic-experienced patients hospitalized with acute severe ulcerative colitis, off-label, high-intensity doses of tofacitinib (Xeljanz) given with intravenous corticosteroids may have reduced ...

If you have a certain autoimmune condition, your doctor may recommend tofacitinib IR oral tablets. Autoimmune conditions cause your immune system to become overactive and attack your own body.

Please provide your email address to receive an email when new articles are posted on . Tofacitinib demonstrated efficacy among older, biologic-naive patients. No major cardiovascular events were ...

Favorable outcomes were observed among patients with vitiligo who received systemic Janus kinase inhibitors, with tofacitinib associated with the highest rate of complete resolution. Tofacitinib may ...

New York, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Tofacitinib Global Market Report 2023" - https://www.reportlinker ...

Please provide your email address to receive an email when new articles are posted on . Patients with rheumatoid arthritis who received tofacitinib demonstrated a greater risk for major adverse ...

In the summer of 1993, Dr. Paul Changelian, a scientist in Pfizer’s immune suppression group, was looking for a new way to prevent organ transplant rejection. Paul, always on the lookout for new ideas ...

Discover comprehensive details about Tofacitinib, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

Oral tofacitinib (Xeljanz), a JAK inhibitor, helped regrow hair in three quarters of pediatric patients with alopecia areata (AA) in a small study conducted at the University of Colorado and published ...

Tofacitinib, with methotrexate, is recommended as an option for treating active psoriatic arthritis in adults, only if: it is used as described in NICE's technology appraisal guidance on etanercept, ...

The US Food and Drug Administration (FDA) approved a supplemental new drug application for tofacitinib (Xeljanz, Xeljanz XR) that adds active ankylosing spondylitis in adults to its list of ...